-type natriuretic peptide (BNP) is a member of the natriuretic peptide hormone family, characterized by a common 17-amino-acid ring and shared biological function (ie, their effect on the cardiovascular system). BNP is secreted from the cardiac ventricles in response to volume expansion and pressure overload.
(BP) and hypertension, 5, 6 type 2 diabetes mellitus, 7, 8 echocardiographic indices, diastolic dysfunction, and congestive heart failure. 9 Thus, in elucidating the genetic architecture of BNP concentration, we are likely to understand the biological basis of these associations. Recently, Del Greco et al 10 in the first ever genome-wide association (GWA) study discovered and replicated a genome-wide significant signal in the MTHFR-CLCN6-NPPA-NPPB gene cluster associated with N-Terminal-proBNP (the inactive form of plasma BNP that is also secreted by cardiac myocytes) 11, 12 in populations of European ancestry. Previously, Benjamin et al 13 reported a genome-wide significant locus associated with circulating BNP concentration in the Framingham Heart Study, although that finding has not been replicated. Overall, there is compelling evidence that genetic factors play a key role in the regulation of BNP concentrations. Except for one study which found that corin serine protease cleaves proANP (proatrial natriuretic peptide) and proBNP converting them into biologically active peptide hormones in populations of African ancestry, 14 most genetic studies have focused on populations of European ancestry. We have performed the first meta-analysis of GWA studies for BNP concentration in blacks. We aimed at identifying novel BNP-associated variants/loci and at evaluating the independence of the associations for singlenucleotide polymorphisms (SNPs) at nearby loci. We further characterized the novel loci by evaluating evidence of their association with aldosterone/renin ratio (ARR), BP, renal traits, and left ventricular mass (LVM) in blacks, Hispanics, and Europeans.
Materials and Methods

Data and Recruitment of Subjects
The study population was recruited between September 2000 and March 2004 from the Jackson, MS metropolitan statistical area, that is, Hinds, Madison, and Rankin Counties using 4 strategies: (i) All living Jackson MS participants enrolled in the Atherosclerosis Risk in Communities (ARIC) study aged 35 to 84 years at initiation of the study were invited to participate. They constitute 31% of the Jackson Heart Study (JHS) participants and we hereby refer to this group of participants as the ARIC and JHS overlap (ARIC-JHS), and this was used as a replication sample in the present investigation; (ii) a random sample (17%) recruited from a commercially available list (AccuData Integrated Marketing, Fort Myers, FL) of all community residents 35 to 84 years of age in the tricounty area; (iii) a volunteer sample (30%) aged 35 to 84 years who responded to targeted advertisements: radio, newspaper, local churches, and civic/social organizations (these volunteers were representative of the Jackson metropolitan statistical area black population in terms of age, sex, and socioeconomic characteristics); (iv) family members (22%), mainly family members of enumerated households including those <35 years for purposes of genetic studies. Participants recruited in strategies (ii) to (iv) are hereby referred to as the JHSspecific sample. The final study sample consisted of 5301 men and women between the ages of 21 and 94 and has been reported to be geographically representative of the age-eligible blacks in the Jackson metropolitan statistical area. 15 Of the total recruited participants, 3029 or 57.1% (892 ARIC-JHS overlap and 2136 JHS specific) gave consent for genetic analyses and thus were genotyped separately in the CARe consortium 16 using Affymetrix 6.0 platform (see Material in the Data Supplement). The ARIC-JHS overlap samples were genotyped together with the larger ARIC subset and JHS specific with the larger JHS subset. In recognition of the separate genotyping, we performed 2 separate GWA and then meta-analyzed the results. The study protocol was approved by the University of Mississippi Medical Center Internal Review Board committee on human subjects.
Relevance of BNP GWA Results to Parallel GWA of Aldosterone and Renin in Samples of European Ancestry
Because of the paucity of cohorts of African ancestry with available BNP concentration measures and GWA data, we sought to assess our results by conducting a cross-check of the identified BNP-associated novel loci in the GWA results of ARR in a large European consortium available to us through our collaborators. This large consortium included 4 studies: Framingham Heart Study, Study of Health in Pomerania, Cooperative Health Research in the Augsburg Region, and Supplementation en Vitamines et Mineraux Antioxiydants Study. This step was motivated by the known reciprocal action of BNP and ARR. Together with atrial natriuretic peptide, BNP blocks cardiac sympathetic nervous system activity and inhibits the reninangiotensin-aldosterone axis. 17 In clinical studies, when heart failure patients are treated aggressively with angiotensin-II receptor antagonists, such treatment often results in reduced BNP concentrations. 18, 19 Evidence from animal studies indicates that BNP inhibits renin synthesis, angiotensin-II generation, and angiotensin-associated aldosterone synthesis in the adrenal glands. 20, 21 Thus, there is evidence that links BNP and the ARR pathways, thereby providing an incentive for assessing commonality in GWA hits for a prototype marker of the pathways.
Inclusion and Exclusion Criteria
Participants with self-reported congestive heart failure or with BNP >100 pg/mL (n=84), serum creatinine levels >2.0 mg/dL, that is, representing renal insufficiency (n=35), and missing BNP measurements (n=26) were excluded from the present analysis. In total, we retained 2036 participants in the JHS-specific sample and 754 in the ARIC-JHS sample (Table 1) . 
BNP Measurement
Of the participants that attended the Jackson Heart examination cycle 1, a total of 4093 (77%) from the entire sample were assayed for plasma BNP using chemiluminescent immunoassay performed on the Siemens Advia Centaur (Siemens) with the assay's limit of detection of 2.0 pg/mL. The intra-assay coefficients of variation are reported elsewhere. 22 Genotyping, quality control, and imputation are presented in the Materials in the Data Supplement.
Statistical Analysis
We log-transformed BNP concentration before using Tobit regression models 23 to generate sex-specific residuals because of the skewed and left censored distribution (caused by the assay's limit of detection) of BNP concentration. The diagnostic assessment had a limit of detection of 2.0 pg/mL and affected 25% and 14% participants in the JHSspecific and ARIC-JHS overlap samples, respectively. Tobit regression permits analysis of all data unlike conventional regression methods. 6, 10 We adjusted for age, sex, body mass index, systolic and diastolic BP, antihypertensive therapy, history of myocardial infarction, diabetes mellitus, atrial fibrillation, serum creatinine, and 10 principal components to account for population stratification. The natriuretic peptide residuals were then standardized within sex (mean=0 and variance=1) and tested for association with imputed SNPs using an additive genetic model. We used a linear regression framework implemented in the MACH2QTL version 1.08 software 24 for both samples. The individual sample GWA results were then combined through meta-analysis using METAL software, 25 which uses inverse-variance-weighted fixed-effects models to combine beta coefficients and standard errors from sample-level regression results for each SNP to derive pooled estimates. The meta-analyzed results were corrected for λ by multiplying the standard errors (SE) of the regression coefficients by the square-root of the study-specific λ. To correct for multiple testing, we declared a significance threshold level a priori of P≤2.5×10 −8 because of the small LD blocks in populations of African ancestry. We used LocusZoom, a web-based tool developed by Pruim and colleagues 26 to inspect regions showing association to determine the extent of the association signal and the position relative to nearby genes.
Conditional analysis was conducted in the individual sample GWA by adding the dosage of the SNP with the strongest association signal at the locus of interest into the regression model as a covariate and testing the residual association with all remaining SNPs within ±500 kb flanking region. We used ProbABEL software package version 0.1.3 27 to run GWA after adjusting for rs198389 and rs3733402 and 10 principal components. We used Wald test to identify SNPs with strong association signals after accounting for the leading SNP.
In the reciprocal look-up (ie, cross-checking the association of variant related to BNP levels with another trait) of the ARR GWA results (Figure 1 ), we restricted analyses to the top 12 SNPs around the loci of the 2 leading variants observed in our meta-analysis results. We set a threshold for declaring significance at 0.05/12 SNPs=4.16×10 −3 . Furthermore, we also attempted to characterize the potential pleiotropic effects of the novel loci by evaluating their association with traits that are physiologically related to BNP concentration (Spearman correlations are provided on Table I in the Data Supplement), such as systolic BP, LVM, chronic kidney disease, glomerular filtration rate, and microalbuminuria in blacks (COGENT, GENOA), European Americans (EchoGEN, CKDGen), and Hispanic Americans (NOMAS).We used a nominal P (P≤0.05) to declare a significant association for these latter look-ups. In addition, we estimated the genetic effects of BNP-associated novel SNPs on plasma BNP concentration. We adjusted for age, sex, body mass index, BP medications, systolic BP, creatinine, type II diabetes mellitus, and significant principal components. Table 1 summarizes the characteristics of the 2 study samples (JHS specific and ARIC-JHS overlap) that we had meta-analyzed. Compared with the JHS specific, the ARIC-JHS overlap sample was older (>17 years) and had a higher prevalence of hypertension, stroke, and diabetes mellitus. The median plasma BNP concentration was also higher in the ARIC-JHS sample (10.7 pg/mL) than in the JHS specific (5.8 pg/mL), and 14 and 25%, respectively, had plasma BNP concentrations less than the limit of detection.
Results
Characteristics of Study Participants
Meta-Analysis of Association Results of ARIC-JHS and JHS-Specific Samples
The meta-analyzed GWA results of plasma BNP concentration are summarized in the Manhattan plot ( Figure 2A ) and QQ plot ( Figure 2B ). The inflation factors (λ) for ARIC-JHS and JHS-specific genome-wide association study analyses were 0.998 and 1.029, respectively, whereas the meta-analysis λ was 1.02, suggesting controlled cryptic relatedness in all analyses. We present regions showing association signals across the genome in regional association plots shown in Figure 3A (rs198389) and Figure 3B (rs3733402). These SNPs are located within NPPB and KLKB1 loci, respectively.
We identified a total of 12 SNPs that were genome wide significantly associated with BNP concentration: 3 SNPs at the 1p36.22 locus and 9 SNPs at the KLKB1 (4q35.2) locus (Table 2) . In Table 2 , we show their base pair positions and distance from the nearest gene and type. The 3 genomewide significant (rs198389, minor allele frequency=0. 40 ) SNPs in chromosome 1p36.22 were clustered around the promoter region of the NPPB gene. The other 9 SNPs were clustered around the Kallikrein plasma factor (KLKB1) gene. Rs3733402 is a missense mutation; rs1511801, rs2048, and rs4253238 were upstream of KLKB1; and the rest were intronic. The G allele of the leading SNP rs3733402 (minor allele frequency=0.27) is associated with increased plasma BNP concentrations [β(SE) 0.20(0.03); P=1.75×10 −11 ]. To explore the presence of additional signals at the BNPassociated loci, we performed conditional analyses at NPPB and KLKB1 loci separately by conditioning on the lead SNPs rs198389 and rs3733402, respectively, and tested the residual association with all the remaining SNPs within±500 kb flanking regions of these lead SNPs. None of the top SNPs tested in conditional analysis remained significantly associated with BNP concentration (Table II of the Data Supplement). The drop in the strength of the association signal implied that rs198389 and rs3733402 were likely the sole drivers behind most of the association signals at NPPB and KLKB1 loci, respectively.
Reciprocal Look-Ups of Genome-Wide Results
The characteristics of the study population used for reciprocal look-up are provided in the companion article by (Lieb et al. [2014] . 28 We looked up the lead SNPs near NPPB and KLKB1 loci for evidence of association with ARR in European discovery data. All the 12 SNPs we identified on chromosome 4q35.2 were significantly (P≤4.16×10 −3 ) associated with ARR in Europeans (Table 3) , although all the effects of the index alleles were in the opposite direction of the effect on BNP concentrations. Alleles associated with increased BNP concentration were associated with low ARR levels in the European samples. Furthermore, the allele frequencies of the effect alleles were always higher than in our study. The SNPs around the NPPB locus were not significantly associated with ARR, although the direction of the effect was consistent.
In additional look-ups, we characterized the association of the identified novel loci with physiologically correlated traits across multiethnic cohorts. Initially, we confirmed correlations of the traits with BNP concentration in our study population, and as presented in Table I in the Data Supplement, all Spearman correlations were strong and highly significant (P<0.001).
The index allele of rs198389 (NBBP locus) was significantly associated with systolic BP in blacks (P=0.019) and with LVM in Europeans (P=0.05), whereas the index allele for rs3733402 was associated with LVM (P=0.048) in Europeans (Table 4) . We observed a borderline significant association of rs198389 (P=0.073) and rs3733402 (P=0.071) with microalbuminuria and chronic kidney disease, respectively, in Europeans only (Table 4) . Associations with the remainder of the correlated traits were not significant.
We also characterized the association of the novel loci with BNP concentrations in its untransformed units. We found that a unit increase in the dosage of the effect allele at the NPPB and KLKB1 loci was significantly associated with 8.1±2.1 pg/mL (P=1.38×10 −4 ) and 8.3±2.2 pg/mL (P=1.38×10 −4 ) of plasma BNP concentration, respectively (Table 5 ). We also observed that subjects with 2 copies of the effective allele showed 15.3 and 14.2 pg/mL higher concentrations than subjects with none (Table 5) .
Discussion
In our first ever GWA analysis of plasma BNP concentration in a sample population of black ancestry, we identified 2 loci NPPB (rs198389) and KLKB1 (rs3733402) that were genome wide significantly associated with BNP concentration. We confirmed previously reported NPPB locus and provided convincing evidence of a novel BNP-associated locus near KLKB1 using a meta-analysis and reciprocal look-ups of GWA results of ARR levels in people of European ancestry. Each additional copy of effective allele for both variants was associated with increased plasma BNP concentration in this community-based black population. Through look-up of GWA results of traits related to plasma BNP concentration in multiethnic populations, we found evidence that these genes probably have pleiotropic effects. Conditional analyses did not reveal any additional SNPs at the loci.
The genome-wide significant association of rs198389 with BNP concentration is the first evidence from GWA showing the association in blacks, although several previous candidate gene studies have investigated the NPPA/NPPB for association with BNP concentrations 6, 29, 30 and with traits physiologically related to BNP such as ventricular dysfunction, 9 BP/hypertension, 5,6 type 2 diabetes mellitus, 8, 31 N-terminal-proBNP, 5,10 and echocardiographic indices. 5 In the majority of these studies, rs198389 is used as a genetic variant to represent variation at the NPPB locus. A recent GWA on serum N-terminal-proBNP in Europeans supplied additional evidence on the genetic role of NPPB locus. This association of the NPPB locus with plasma BNP concentration may be a reflection of the function of NPPB in the synthesis of circulating BNP. The NPPB gene has been previously described as having a role in encoding for the preproBNP precursor. After removal of a 26-amino-acid signal peptide from this protein, it becomes a 108-amino-acid proBNP polypeptide. Further processing of this polypeptide results in a physiologically active 32-amino-acid carboxylterminal BNP molecule (BNP 32 ) and an inactive N-terminal fragment (BNP). 11 Meirhaeghe and colleagues 31 recently demonstrated that there is an increased promoter activity in vitro of the C allele of rs198389 SNP in patients with type 2 diabetes mellitus. They also observed that COS7 cells transfected with C allele showed higher BNP gene transcription compared with T allele. 10, 31 Distribution of the C allele in the general adult population has been reported to be common but has no effect on cardiovascular outcome. 32 To refine and thus better explain the association signal at the NPPB locus in our study, we generated LD plots centered on rs198389 but within 25 kb across YRI and CEU ( Figure  IA and IB in the Data Supplement). LD around rs198389 extends along a 9-kb region in HapMap CEU (release 3) and contains all SNPs previously associated with plasma BNP and serum proBNP in populations of European ancestry. However, the interval is only 3 kb in YRI and contains rs6668659 only, which has previously been associated with plasma BNP in effect allele. This difference in the LD block between CEU and YRI may explain the difference in the polymorphisms with the strongest association signal at the NPPB locus in our study compared with previous studies in whites. 6 Our finding that a missense SNP (rs3733402) on human KLKB1 is genome wide significantly associated with plasma BNP concentration is novel and has not been previously reported. Rs4253238, which is in complete LD (r 2 =1.00) with rs3733402, was recently found to be associated with midregional proadrenomedullin in individuals of European ancestry. 33 KLKB1 is known to encode plasma kallikrein, a serine protease synthesized in the liver as plasma prekallikrein, and when secreted into the blood it is converted into plasma kallikrein. 34 The plasma kallikrein controls the release of bradykinin and activates conversion of prorenin to renin. Previous research work to identify polymorphisms of KLKB1, and their linkage analysis to end-stage renal disease among blacks yielded inconclusive results. 35 Despite these findings, the role of plasma kallikrein in the regulation of BP and renal perfusion through secretion of kinins and vasopeptides 36 qualifies as a candidate gene for essential hypertension and chronic renal failure (conditions, both of which are associated with plasma BNP concentration through its biological effects on peripheral and renal vasculature). 37 In candidate gene studies, Lu and colleagues 38 found that genetic variation at the KLKB1 is associated with an increased risk of essential hypertension in Han Chinese. Thus, it is in this regard that we pursued a reciprocal look-up of ARR GWA results for evidence of pleiotropic effects of the KLKB1 locus. Plasma BNP concentration is linked to RAAS through its role as a counterregulatory peptide that is protective in conditions of overactivation of RAAS (such as in heart failure). Natriuretic peptides lower renin and aldosterone concentrations and decrease angiotensin II-stimulated aldosterone secretion. These actions result in a natriuretic effect that is compensatory although limited in volume overload conditions. 39 Our results corroborate this inverse relation, in that alleles responsible for higher plasma BNP are associated with a decrease in ARR (Table 3 ). The lack of a similar significant association between the ARR and rs198389 SNP in the NPPB gene underscores a possible complex pleotropic relationship between rs198389 SNP on NPPB gene and ARR traits. Pleoitropy can be either direct (ie, a gene influences single gene traits) or indirect 40 (ie, a single gene influences traits in multiple pathways).
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Statistically significant associations in additional look-ups of rs198389 and rs3733402 with systolic BP in participants of African ancestry and with LVM in individuals of European ancestry (Table 4 ) are supported by biological data. For instance, BNP is known to promote vasodilation, inhibit vasoconstriction, and lower sympathetic tone and, thus, it lowers BP. 2 Findings from animal studies using transgenic mice that overexpress BNP show that the systolic BP is 20 to 30 mm Hg lower in affected mice compared with their normal counterparts. 41 The link between BNP and LVM is also well established. BNP is primarily synthesized, stored, and released by the ventricular myocardium in response to increased wall stress. 2, 42 As a result of its relation to the ventricular myocardium, BNP concentrations are higher in patients with heart failure. Currently, BNP concentrations are clinically used as a part of the diagnostic workup for heart failure. 43 In the JHS cohort, higher BNP concentrations are significantly associated with higher echocardiographic LVM. Furthermore, the natriuretic peptide system is strongly related to kidney function through both renal artery hemodynamics and direct tubular effects. Natriuretic peptide increases blood flow to the kidneys through vasodilation of the renal arteries, thus promoting diuresis. 2, 44, 45 Natriuretic peptide more directly causes dilatation of afferent arterioles and constriction of efferent arterioles in the tubules, leading to increased glomerular filtration. 2 The nominally significant associations of BNP GWA SNPs with both plasma BNP and LVM are consistent with the notion that genetic variation in BNP concentrations may impact target organ damage such as left ventricular hypertrophy. BNP knockout mice develop cardiac fibrosis and left ventricular hypertrophy. 46 Because human knockouts do not exist, the present GWA allows us to characterize their association with LVM in the community.
We also examined the interaction between the top genomewide association study loci through pathway analysis, which would provide another potential route to investigate the collective effects of genetic variants on biological systems. Multiple pathways were found to be enriched with BNP-related genes, but the evidence was inconclusive and warrants further investigation (Material in the Data Supplement) to understand the definite mechanism underlying these associations.
Strengths and Limitations
To date, this is the largest GWA study of BNP concentration in a community-based sample of blacks. Previous candidate gene-based analyses were limited to specific genes that were suspected to influence genetic variation of plasma BNP concentration. This study allowed us to test several other regions in the genome for a possible association with BNP concentration. Our results confirm findings on the NPPB locus and report 1 novel SNP in the KLKB1 locus. The lack of an appropriate replication sample is a major limitation of the study. Although we exploited a possible reciprocal relation between BNP and ARR to cross-check the relevance of our GWA results and lookups of association results from physiologically related traits to characterize the effects of our findings, replication is usually the standard procedure of ensuring credibility of genotype-phenotype associations. Furthermore, the unavailability of genotype data on the missense corin variants barred us from checking the widely known association with natriuretic peptides in blacks.
Conclusion
We conducted the first GWA analysis of plasma BNP concentrations in blacks and confirmed that all the genetic variants with the strongest effects are within and around the NPPB and KLKB1 genes, both of which are determinants of BP control and hypertension. Although we were constrained by a relatively small sample size, and therefore a potentially lower statistical power to detect weak effect sizes, we were able to successfully characterize the association of these loci with other traits through look-ups. Larger sample sizes of black samples will likely confirm these results and facilitate discovery of more loci regulating plasma BNP concentrations.
